Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Nature Communications|May 31, 2017
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cellsTetsuro Yoshimaru, Masaya Ono, Yoshimi Bando, et al.
Clinical Breast Cancer|January 21, 2015
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast CancerAyako Yanai, Natsuko Inoue, Tomoko Yagi, et al.
International Journal of Clinical Oncology|March 1, 2008
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in JapanToshiaki Saeki, Muneo Sano, Yoshifumi Komoike, et al.
International Journal of Clinical Oncology|September 5, 2015
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancersYukie Enomoto, Takashi Morimoto, Arisa Nishimukai, et al.
Japanese Journal of Clinical Oncology|April 7, 2004
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancerYusuke Oji, Yasuo Miyoshi, Eiji Kiyotoh, et al.
Anticancer Research|June 4, 2021
Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13)Mayuko Miki, Shintaro Takao, Muneharu Konishi, et al.
Anticancer Research|October 3, 2022
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 InhibitorsHaruka Kanaoka, Masayuki Nagahashi, Yusa Atake, et al.
Breast Cancer Research : BCR|October 21, 2024
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4BWenwen Wu, Jing Zhu, Naoe Taira Nihira, et al.
Breast (Edinburgh, Scotland)|July 17, 2023
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, et al.
Breast Cancer (Tokyo, Japan)|August 7, 2013
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosisTomohiro Miyake, Takashi Ito, Ayako Yanai, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Nature Communications|May 31, 2017
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cellsTetsuro Yoshimaru, Masaya Ono, Yoshimi Bando, et al.
Clinical Breast Cancer|January 21, 2015
Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast CancerAyako Yanai, Natsuko Inoue, Tomoko Yagi, et al.
International Journal of Clinical Oncology|March 1, 2008
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in JapanToshiaki Saeki, Muneo Sano, Yoshifumi Komoike, et al.
International Journal of Clinical Oncology|September 5, 2015
Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancersYukie Enomoto, Takashi Morimoto, Arisa Nishimukai, et al.
Japanese Journal of Clinical Oncology|April 7, 2004
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancerYusuke Oji, Yasuo Miyoshi, Eiji Kiyotoh, et al.
Anticancer Research|June 4, 2021
Investigation of a Novel S-1 Administration Schedule for Treating Metastatic and Recurrent Breast Cancer (KBCOG13)Mayuko Miki, Shintaro Takao, Muneharu Konishi, et al.
Anticancer Research|October 3, 2022
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 InhibitorsHaruka Kanaoka, Masayuki Nagahashi, Yusa Atake, et al.
Breast Cancer Research : BCR|October 21, 2024
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4BWenwen Wu, Jing Zhu, Naoe Taira Nihira, et al.
Breast (Edinburgh, Scotland)|July 17, 2023
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)Hiroko Masuda, Yuko Tanabe, Hitomi Sakai, et al.
Breast Cancer (Tokyo, Japan)|August 7, 2013
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosisTomohiro Miyake, Takashi Ito, Ayako Yanai, et al.
Pageof 18